Literature DB >> 3673667

Autonomic neuropathy in type I diabetes: influence of duration and other diabetic complications.

B Bergström1, B Lilja, S Osterlin, G Sundkvist.   

Abstract

To evaluate the influence of duration on the development of autonomic neuropathy (AN) a group of type I diabetic patients (n = 58) who had been diagnosed between the ages of 15 and 25 years was investigated. The duration of diabetes varied from 2 months to 30 years (mean 13 years). AN tests included a deep breathing test (E/I ratio) and an orthostatic test on tilt table (acceleration and brake indices) and the results were corrected for age. A clear correlation between AN test and duration of diabetes was shown only for the E/I ratio (r = -0.44, p less than 0.001). On the other hand, deteriorations in the brake index were unrelated to the duration of diabetes and occurred early; 35% of the patients with a duration of 10 years or less showed an abnormal brake index. Autonomic test deviations were related to other diabetic complications. The E/I ratio and the acceleration index were especially low in patients with retinopathy as well as in patients with symptoms of AN if combined with peripheral neuropathy (PN). The brake index was low in patients with symptoms of AN independent of PN.

Entities:  

Mesh:

Year:  1987        PMID: 3673667     DOI: 10.1111/j.0954-6820.1987.tb10652.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  9 in total

1.  Glutamic acid decarboxylase antibodies, autonomic nerve antibodies and autonomic neuropathy in diabetic patients.

Authors:  G Sundkvist; L A Velloso; O Kämpe; S L Rabinowe; S A Ivarsson; B Lilja; F A Karlsson
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

2.  Autonomic nerve dysfunction in patients with bolus-specific esophageal dysmotility.

Authors:  O Ekberg; R Olsson; H Nilsson; B Lilja; G Sundkvist
Journal:  Dysphagia       Date:  1995       Impact factor: 3.438

3.  The activity of the renin-angiotensin-aldosterone system before and during submaximal bicycle exercise in relation to circulatory catecholamines in patients with type 1 (insulin-dependent) diabetes mellitus.

Authors:  G Sundkvist; B Bergström; M Bramnert; B Lilja; P Manhem
Journal:  Diabetologia       Date:  1990-03       Impact factor: 10.122

4.  A prospective study of orthostatic blood pressure in diabetic patients.

Authors:  M de Kanter; B Lilja; S Elmståhl; K F Eriksson; G Sundkvist
Journal:  Clin Auton Res       Date:  1998-08       Impact factor: 4.435

5.  Cross-sectional study of peripheral microcirculation in diabetic patients with microangiopathy: influence of pancreatic and kidney transplantation.

Authors:  M Gfesser; J Nusser; W Müller-Felber; D Abendroth; W Land; R Landgraf
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

6.  Increased arterial stiffness in women, but not in men, with IDDM.

Authors:  A Rydén Ahlgren; T Länne; P Wollmer; B Sonesson; F Hansen; G Sundkvist
Journal:  Diabetologia       Date:  1995-09       Impact factor: 10.122

7.  Electrocardiographic changes with the onset of diabetes and the impact of aerobic exercise training in the Zucker Diabetic Fatty (ZDF) rat.

Authors:  Lisa VanHoose; Youssef Sawers; Rajprasad Loganathan; James L Vacek; Lisa Stehno-Bittel; Lesya Novikova; Muhammed Al-Jarrah; Irina V Smirnova
Journal:  Cardiovasc Diabetol       Date:  2010-09-22       Impact factor: 9.951

8.  Temporal trend of autonomic nerve function and HSP27, MIF and PAI-1 in type 1 diabetes.

Authors:  Malin Zimmerman; Sara Rolandsson Enes; Hanna Skärstrand; Kaveh Pourhamidi; Anders Gottsäter; Per Wollmer; Olov Rolandsson; Gunilla Westergren-Thorsson; Lars B Dahlin
Journal:  J Clin Transl Endocrinol       Date:  2017-03-20

9.  Autonomic Neuropathy-a Prospective Cohort Study of Symptoms and E/I Ratio in Normal Glucose Tolerance, Impaired Glucose Tolerance, and Type 2 Diabetes.

Authors:  Malin Zimmerman; Kaveh Pourhamidi; Olov Rolandsson; Lars B Dahlin
Journal:  Front Neurol       Date:  2018-03-14       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.